Insider buying last 90 days
No open-market insider purchases were filed for OMDA in the last 90 days.
From Form 4 filings, dated to when each was filed.
Every OMDA insider filing, plotted on the chart in Gekko.Open OMDA in Gekko
NASDAQ: OMDA
Omada Health (OMDA) Stock Analysis & Forecast
Oct 12 close
$21.87+0.32 (+1.5%)
Gekko Brief
AI summaryOct 12 closeOmada Health's quarterly results and outlook dominate recent news. The company reported its strongest quarter ever in Q2 2026, with record revenue of $88 million, up 43% year-over-year, and GAAP gross margin expanding to 73%. Full-year 2026 revenue guidance was raised to $334-340 million, with adjusted EBITDA guidance lifted to $21-27 million. Total members reached 1.1 million, up 45% year-over-year, and the company generated $5 million net income and $11 million adjusted EBITDA versus a loss in the prior-year period. Alongside these results, CEO Sean Duffy announced a transition to Executive Chairman, with Wei-… named to succeed him.
OMDA closed at $21.87, up 1.5%, sitting almost exactly at its 50-day average of $21.88 and well above its 200-day average of $17.47. The stock has gained 11.2% over the past month and 80.4% over six months, though it remains down 9.7% over the past year. The GekkoIndex reads 56.2, placing it in the Neutral zone, down 6.1 points over five days. Gekko Fair Value stands at $24.47, putting the current price 10.6% below that level.
Earnings are scheduled for 5 November 2026, after the close, 24 days away and inside a typical 20-trading-day holding window; the prior report saw a 23.9% reaction versus an average absolute move of 9.9%. Analyst coverage from 12 firms shows 11 buy ratings and 1 hold, with a consensus target of $28.42, implying 29.9% upside. No insider, Congress, or unusual options activity appears within their respective windows.
Written by AI from the Oct 12, 2026 close and checked automatically against the figures on this page.
Omada Health price vs fair value
Close $21.87200-day averageGekko Fair Value $24.47
Omada Health quick facts
- Market cap
- $1.30B
- P/E ratio
- 86.8
- Forward P/E
- 137
- EPS, TTM
- $0.24
- Revenue, TTM
- $309.8M
- Profit margin
- 1.4%
- Dividend yield
- —
- Beta
- —
- Volume
- 594,683 avg 1.27M
- 1-year return
- −9.7%
- Typical daily move
- ±4%
- Typical 20-day move
- ±13.8%
- 50-day average
- $21.88
- 200-day average
- $17.47
- Next earnings
- Nov 5 after close
- Shares outstanding
- 61.22M
Omada Health swing-trade checklist
Omada Health scores 1 supportive, 2 mixed and 1 headwind across the 4 checklist items with data.
Six things swing traders check before a 20-day hold, read from the latest data.
1 supportive2 mixed1 headwind
- Trendmixed
Averages disagree
Close $21.87 sits between the 50-day ($21.88) and 200-day ($17.47) averages, or the averages disagree.
See the chart - GekkoIndexmixed
56.2, Neutral
Reading 56.2 is in the Neutral zone.
See the GekkoIndex - Fair valuesupportive
10.6% below
Price is 10.6% below Gekko Fair Value (more than 5% below).
See fair value - Smart moneyno data
No data
No insider, Congress or unusual options activity in the window.
See smart money - Earnings riskheadwind
Reports in 24 days
Reports on Nov 5, 2026, 24 days away — inside a typical 20-trading-day hold.
See earnings - Seasonalityno data
No data
Not enough years of history for a seasonal read.
A description of current data, not a recommendation. How this page works
Omada Health stock chart and price history
Omada Health closed at $21.87 on Oct 12, 2026, −9.7% over the past year, inside a 52-week range of $10.28 to $26.92.
Close50-day average200-day averageVolume
Use the left and right arrow keys to read daily values.
Performance Breakdown
- 1 month
- +11.2%
- 3 months
- −6.7%
- 6 months
- +80.4%
- 1 year
- −9.7%
The full OMDA chart adds GekkoIndex, insider, options, Congress and hedge fund markers, plus TrendCandles™.Open OMDA in Gekko
Follow Omada Health through every session
Put OMDA on a Gekko watchlist and see its GekkoIndex, Gekko Fair Value and smart money signals update on the chart as they change.
Track OMDA in GekkoFree for 7 days. No credit card required.
Omada Health GekkoIndex: the smart money zone
Omada Health’s GekkoIndex — Gekko’s 0 to 100 smart money score — reads 56.2, in the Neutral zone, down 6.1 points over five sessions.
56.2Neutral
Down 6.1 points over five sessions, from the Accumulation zone.
Reading for Oct 12, 2026
What followed past readings in each zone
| Zone | Readings | 5 days | 20 days | ||
|---|---|---|---|---|---|
| Buying | 36 | −2.3% | +3.6% | ||
| Accumulation | 111 | +1.5% | +3.7% | ||
| Neutral (current zone) | 161 | +0.8% | +2.3% | ||
| Distribution | 25 | −1.5% | −1.2% | ||
| Selling | 0 | Not available | |||
Average OMDA share-price change over the trading days after each daily reading in its GekkoIndex history. Across every stock Gekko tracks, Neutral readings averaged +1.1% over 20 days. Past behaviour doesn’t guarantee future results.
Neutral zone: No clear directional signal. About the five zones →
See every daily GekkoIndex reading plotted over the OMDA price, zone by zone.Track OMDA in Gekko
Is Omada Health stock overvalued? Gekko Fair Value
Omada Health trades 10.6% below Gekko Fair Value of $24.47, so the shares are undervalued on Gekko’s estimate.
Gekko’s own estimate of what Omada Health shares are worth, recalculated every trading day.
$24.47
Gekko Fair Value, Oct 10, 2026
10.6% Undervalued
At the end of Aug 2026 the price was 6.2% below the estimate.
Gekko Fair ValueShare price, month end
Gekko Fair Value on every chart, with the gap to price updating daily.Open OMDA in Gekko
Omada Health insider and Congress trading
No open-market insider purchases were filed for Omada Health, and no Congress trades were disclosed, in the last 90 days.
Plus buybacks, unusual options and fund positions, each dated to when it became public.
Congress trades last 90 days
No trades in OMDA were disclosed by members of Congress in the last 90 days.
From congressional disclosures, which report amounts as ranges.
Congress disclosures for OMDA, plotted on the chart in Gekko.Open OMDA in Gekko
Hedge funds and billionaires quarter ended Sep 30
0of the funds Gekko tracks hold OMDA.
0added0opened0trimmed2sold out
Which funds are on each side, name by name.Unlock in Gekko
Omada Health earnings: next date and track record
Omada Health reports on Nov 5, 2026, after the close (24 days away), and beat the EPS estimate in 5 of its last 6 reports.
Next earnings report
Nov 5, 2026
Expected after the close, 24 days away
- EPS estimate
- $0.07
- Revenue estimate
- $85.64M
5 of 6reports beat the EPS estimate
±9.9%average move across the report
2 of 5reports followed by a gain
Share-price move across each report
Last earnings call, Aug 6, 2026 AI summary
- What they said
- Omada Health reported its strongest quarter ever in Q2 2026, achieving 43% year-over-year revenue growth and expanding GAAP gross margin by 700 basis points to 73%. Total members reached 1.1 million, up 45% year-over-year. The company generated $5 million net income and $11 million adjusted EBITDA versus a loss in the prior year period. CEO Sean Duffy announced he will transition to Executive Chair on January 1, 2027, with President Wei-Li Shao assuming the CEO role.
- Guidance
- Management raised full-year 2026 outlook following Q2 results that exceeded consensus estimates. Strategic focus areas include expanding covered lives, GLP-1 integration, and AI-driven personalized care delivery.
| Reported | EPS | Revenue | Move |
|---|---|---|---|
| Aug 6, 2026 | $0.15 est $0.06 | $87.84M est $80.04M | +23.9% |
| May 7, 2026 | $0.01 est −$0.08 | $78.05M est $74.09M | −6.6% |
| Mar 5, 2026 | $0.16 est $0.03 | $75.85M est $70.21M | +3.9% |
| Nov 6, 2025 | $0.02 est −$0.10 | $68.03M est $69.04M | −12.8% |
| Aug 7, 2025 | −$0.09 est −$0.10 | $61.37M est $55.45M | −2.2% |
| May 9, 2025 | −$0.13 est −$0.12 | $54.96M est $55.33M | — |
“Move” is the close of the first session after the report compared with the close of the last session before it, so it reads the same whether the company reported before the open or after the close.
Omada Health stock forecast and analyst price targets
Analysts’ average 12-month price target for Omada Health is $28.42, +29.9% from the last close, from 12 firms rating the stock in the last 90 days.
$28.42consensus 12-month target, +29.9% from the last close
Now $21.87Avg $28.42
Low $22High $35
Each firm’s latest rating in the last 90 days: 12 firms.
Latest analyst actions
| Date | Firm | Target | vs price |
|---|---|---|---|
| Sep 28 | Morgan Stanley | $30 | +37.2% |
| Sep 14 | Wells Fargo | $22 | +0.6% |
| Sep 14 | Freedom Capital Markets | $35 | +60.0% |
| Sep 11 | Barclays | $27 | +23.5% |
| Sep 11 | BTIG | $35 | +60.0% |
+2.3%average 20-day move after past Neutral readings
±4%typical daily move, from the 14-day average range
Gekko doesn’t publish price predictions. These are analyst targets and historical base rates, which don’t guarantee future results.
Omada Health market cap and key statistics
Omada Health’s market cap is $1.30B, with a P/E ratio of 86.8 and revenue of $309.8M over the last twelve months.
Valuation
- Market cap
- $1.30B
- P/E ratio
- 86.8
- Forward P/E
- 137
- EPS, TTM
- $0.24
- Gekko Fair Value
- $24.47
Trading
- Volume
- 594,683
- Avg volume, 20 days
- 1.27M
- 52-week high
- $26.92
- 52-week low
- $10.28
- Shares outstanding
- 61.22M
Financials
- Revenue, TTM
- $309.8M
- Profit margin
- 1.4%
- Return on equity
- 1.8%
- Quarterly earnings growth, YoY
- 0.0%
Risk and income
- Typical daily move
- ±4%
- Typical 20-day move
- ±13.8%
Omada Health stock news this week
Coverage of Omada Health this week reads neutral: 2 positive, 7 neutral and 0 negative headlines.
- Transcript: Omada Health Q2 2026 Earnings Conference CallBenzinga, Oct 12
- Omada Health, Inc. Revenue Breakdown – FWB:U76TradingView, Oct 11
- Form 4 Omada Health Inc For: 10 October By Investing.comInvesting.com South Africa, Oct 11
- Omada Health (OMDA), Why Is The Stock Drawing Fresh Attention?Simply Wall Street, Oct 9
- Omada Health Inc. (OMDA) Stock Price | Live Quotes & Charts | NASDAQTimothy Sykes, Oct 8
- Form 4 Omada Health Inc For: 7 October By Investing.comInvesting.com India, Oct 8
Omada Health peers
Omada Health’s 6 largest industry peers by market value, with today’s move, GekkoIndex zone and gap to Gekko Fair Value.
| Stock | GekkoIndex zone | vs Fair Value |
|---|---|---|
| GOOGLAlphabet | Neutral | 9.6% above |
| GOOGAlphabet | Neutral | 10.2% above |
| METAMeta Platforms | Neutral | 25.5% above |
| NFLXNetflix | Accumulation | 25.2% below |
| SPOTSpotify Technology | Neutral | 18.3% above |
| MSTRStrategy | Neutral | 11.6% below |
A peer links to its own page where one exists.
Omada Health stock FAQ
What is Omada Health’s market cap?
Omada Health’s market cap is $1.30B at the Oct 12, 2026 close of $21.87, with 61.22M shares outstanding. The shares trade on a P/E ratio of 86.8.
What is the Omada Health stock forecast?
The consensus analyst 12-month price target for Omada Health is $28.42, +29.9% from the last close. Of the 12 firms that rated the stock in the last 90 days, 11 rate it a buy, 1 a hold and 0 a sell. Gekko doesn’t publish price predictions of its own.
Is Omada Health stock overvalued or undervalued?
On Gekko’s estimate Omada Health is undervalued: the Oct 12, 2026 close of $21.87 is 10.6% below Gekko Fair Value of $24.47. Gekko Fair Value is recalculated every trading day, and a gap inside 5% either way counts as about fair value.
When does Omada Health report earnings next?
Omada Health is expected to report on Nov 5, 2026, after the market closes (24 days away). Analysts expect earnings of $0.07 per share on revenue of $85.64M. Omada Health beat the earnings estimate in 5 of its last 6 reports, moving 9.9% on average across the report.
What is Omada Health’s 52-week high and low?
Omada Health’s 52-week high is $26.92 and its 52-week low is $10.28; it closed at $21.87 on Oct 12, 2026, −9.7% over the past year. Over the last five years the shares peaked at $28.40 on Jun 6, 2025.
Is Omada Health stock a buy right now?
Gekko describes the data; it does not make buy or sell recommendations. On the swing-trade checklist, 1 of the 4 items with data read as supportive (fair value), 2 as mixed (trend and gekkoindex) and 1 as a headwind (earnings risk). The checklist is a description of current data, not a recommendation.
How this page works
During US trading hours the price at the top of the page is a delayed quote, refreshed every 15 minutes; everything else is rebuilt after each US market close. The GekkoIndex, Gekko Fair Value and the checklist are Gekko’s own, and the Gekko Brief is written by AI from this page’s data and checked against it before it is published. How Gekko’s data works →
See Omada Health the way Gekko members do
Every GekkoIndex reading, insider trade, options bet and Congress disclosure plotted on the chart, plus the 5,800-name screener and trade planning tools.
Join 1,408 other traders using Gekko
Start Your FREE 7 Day Trial → Every feature unlocked. No credit card required.